Quarterly report [Sections 13 or 15(d)]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.26.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of September 30, 2026 and December 31, 2025:

 

    September 30, 2026     December 31, 2025  
Lab supplies   $ 1,271     $ 1,114  
Prepaid expenses     583       632  
Deferred offering costs*     882       -  
Other     22       -  
Total other current assets   $ 2,758     $ 1,746  

 

* Costs related to the preparation of the Company’s S-1 filed in September 2026.
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

    2026     2025     2026     2025  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
Basic weighted average number of common shares     5,705       885       5,210       885  
Potential dilutive effect of stock-based awards     -       1       -       1  
Dilutive effect of preferred stock     -       4,653       -       4,653  
Diluted weighted average number of common shares     5,705       5,539       5,210       5,539  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    2026     2025     2026     2025  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
Options     368       49       368       49  
Restricted stock units (RSUs)     140       27       140       27  
Anti-dilutive securities     508       76       508       76